galactosamine has been researched along with ng-nitroarginine methyl ester in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adawi, D; Jeppsson, B; Molin, G | 1 |
| Asama, T; Iwamoto, J; Kasai, S; Kono, T; Kotani, H; Mamiya, N; Ohara, K; Yoneda, M | 1 |
| Barrera, P; Bernardos, A; De la Mata, M; González, R; López-Cillero, P; López-Sánchez, LM; Muntané, J; Ranchal, I; Rodríguez-Ariza, A; Serrano, J | 1 |
| Kozłowski, W; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Wesołowski, P | 1 |
| Bao, XQ; Liu, GT | 1 |
| Alva, N; Bermudez, J; Carbonell, T; Cruz, D; Sanchez, S; Valentín, JM | 1 |
6 other study(ies) available for galactosamine and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Inhibition of nitric oxide modulates the effect of oral arginine supplementation in acute liver injury.
Topics: Acute Disease; Administration, Oral; Alanine Transaminase; Analysis of Variance; Animals; Arginine; Aspartate Aminotransferases; Bacterial Translocation; Bilirubin; Chemical and Drug Induced Liver Injury; Colony Count, Microbial; Disease Models, Animal; DNA; Enzyme Inhibitors; Food, Fortified; Galactosamine; Intestinal Mucosa; Liver Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; RNA | 1997 |
Protective effect of pretreatment with low-dose lipopolysaccharide on D-galactosamine-induced acute liver failure.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Enzyme Inhibitors; Galactosamine; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred F344 | 2002 |
The differential effect of PGE(1) on d-galactosamine-induced nitrosative stress and cell death in primary culture of human hepatocytes.
Topics: Alprostadil; Cell Death; Cells, Cultured; Enzyme Induction; Female; Galactosamine; Hepatocytes; Humans; Male; Middle Aged; Mitochondria, Liver; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II | 2006 |
[Role of nitric oxide system in pathogenesis of experimental model of hepatorenal syndrome].
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Galactosamine; Hepatorenal Syndrome; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 2008 |
Involvement of HSP70 in the protection of bicyclol on apoptosis of HepG2 cells intoxicated by d-galactosamine.
Topics: Apoptosis; Biphenyl Compounds; Caspase 3; Dose-Response Relationship, Drug; Galactosamine; Hep G2 Cells; Hepatocytes; HSP70 Heat-Shock Proteins; Humans; Molecular Structure; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Stereoisomerism | 2010 |
Nitric oxide as a mediator of fructose 1,6-bisphosphate protection in galactosamine-induced hepatotoxicity in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Fructosediphosphates; Galactosamine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley | 2013 |